Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Future of Point-of-Care Nucleic Acid Amplification Diagnostics after COVID-19: Time to Walk the Walk

15 Nov 2022

Abstract excerpt

Since the onset of the COVID-19 pandemic, over 610 million cases have been diagnosed and it has caused over 6.5 million deaths worldwide. The crisis has forced the scientific community to develop tools for disease control and management at a pace never seen before. The control of the pandemic heavily relies in the use of fast and accurate diagnostics, that allow testing at a large scale. The gold standard...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced biosensing and bioanalysis techniques
Share to Biosensors and Analytical Detection
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36430586
DOI: 10.3390/ijms232214110

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Future of Point-of-Care Nucleic Acid Amplification Diagnostics after COVID-19: Time to Walk the WalkPMID 36430586Read ↗

Recent advances in point of care testing for COVID-19 detectionSemantic proximity Read ↗

Molecular diagnostic assays for COVID-19: an overviewSemantic proximity Read ↗

SARS-CoV-2 Diagnostics Based on Nucleic Acids Amplification: From Fundamental Concepts to Applications and BeyondSemantic proximity Read ↗

Next-Generation Nucleic Acid-Based Diagnostics for Viral Pathogens: Lessons Learned from the SARS-CoV-2 PandemicSemantic proximity Read ↗

Molecular Diagnosis of COVID-19: Challenges and Research NeedsSemantic proximity Read ↗

Advances in nucleic acid amplification techniques (NAATs): COVID-19 point-of-care diagnostics as an exampleSemantic proximity Read ↗

Nucleic Acid Testing of SARS-CoV-2Semantic proximity Read ↗

Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extractionSemantic proximity Read ↗

iSCAN-V2: A One-Pot RT-RPA–CRISPR/Cas12b Assay for Point-of-Care SARS-CoV-2 DetectionSemantic proximity Read ↗

Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplificationSemantic proximity Read ↗

SARS-CoV-2 Direct Detection Without RNA Isolation With Loop-Mediated Isothermal Amplification (LAMP) and CRISPR-Cas12Semantic proximity Read ↗

A high-throughput strategy for COVID-19 testing based on next-generation sequencingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.